资讯

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...